Meta-Analysis of Antidepressant Pharmacotherapy in Patients Eligible for Cardiac Rehabilitation

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Journal of Cardiopulmonary Rehabilitation and Prevention

• Publication date

  2022-06-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/HCR.0000000000000699PMID 35797521PMCID PMC9643590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease: The Understanding the Benefits of Exercise and Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) Randomized Clinical Trial.

  2021cited by this paper
• The ESC Working Group on Coronary Pathophysiology and Microcirculation.

  2020cited by this paper
• Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines.

  2019cited by this paper
• Improvements in Depressive Symptoms and Affect During Cardiac Rehabilitation: PREDICTORS AND POTENTIAL MECHANISMS

  2019cited by this paper
• Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: questionable benefit and considerations for frailty

  2019cited by this paper
• Aerobic exercise alleviates depressive symptoms in patients with a major non-communicable chronic disease: a systematic review and meta-analysis

  2019cited by this paper
• Effect of exercise‐based cardiac rehabilitation on anxiety and depression in patients with myocardial infarction: A systematic review and meta‐analysis

  2019cited by this paper
• Assessing the effectiveness of Enhanced Psychological Care for patients with depressive symptoms attending cardiac rehabilitation compared with treatment as usual (CADENCE): a pilot cluster randomised controlled trial

  2018cited by this paper
• Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial

  2018cited by this paper
• Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis.

  2018cited by this paper
• Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

  2018cited by this paper
• Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis

  2018cited by this paper
• Depression and Anxiety Screening and Triage Protocol for Cardiac Rehabilitation Programs

  2017cited by this paper
• Does service timing matter for psychological outcomes in cardiac rehabilitation? Insights from the National Audit of Cardiac Rehabilitation

  2017cited by this paper
• Severity of Depressive Symptoms Pre- and Postcardiac Rehabilitation: A COMPARISON AMONG PATIENTS IN BRAZIL, CANADA, COLOMBIA, THE UNITED STATES, AND VENEZUELA

  2017cited by this paper
• Influence of Depression on Utilization of Cardiac Rehabilitation Postmyocardial Infarction: A STUDY OF 158 991 MEDICARE BENEFICIARIES

  2017cited by this paper
• Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.

  2016cited by this paper
• Impact of Cardiac Rehabilitation and Exercise Training on Psychological Risk Factors and Subsequent Prognosis in Patients With Cardiovascular Disease.

  2016cited by this paper
• Exercise as a treatment for depression: A meta-analysis.

  2016cited by this paper
• Screening for Depression in Cardiac Rehabilitation: A REVIEW

  2015cited by this paper
• How effective are common medications: a perspective based on meta-analyses of major drugs

  2015cited by this paper
• Psychological Interventions for Coronary Heart Disease: Cochrane Systematic Review and Meta-analysis

  2014cited by this paper
• Behavioral cardiology: current advances and future directions.

  2014cited by this paper
• Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial.

  2013cited by this paper
• Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study.

  2012cited by this paper
• The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

  2011cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Meta-analysis of the placebo response in antidepressant trials.

  2009cited by this paper
• A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.

  2009cited by this paper
• Safety and Efficacy of Sertraline plus Nurse Facilitated Supportive Intervention (NFSI) versus Placebo plus Nurse Facilitated Supportive Intervention for Depression in Patients with CHF (SADHART-CHF) (10/6/08)

  2008cited by this paper
• Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdiscip

  2008cited by this paper
• Treatment of Post-Myocardial Infarction Depressive Disorder: A Randomized, Placebo-Controlled Trial With Mirtazapine

  2007cited by this paper
• A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.

  2007cited by this paper
• Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Pr

  2007cited by this paper
• Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

  2007cited by this paper
• Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Pr

  2007cited by this paper
• Depression screening in cardiac rehabilitation: AACVPR Task Force Report.

  2005cited by this paper
• The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology.

  2005cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Sertraline treatment of major depression in patients with acute MI or unstable angina.

  2002cited by this paper
• Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction.

  2001cited by this paper
• Efficacy and Safety of Fluoxetine in the Treatment of Patients With Major Depression After First Myocardial Infarction: Findings From a Double-Blind, Placebo-Controlled Trial

  2000cited by this paper
• Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis

  2000cited by this paper
• Bias in meta›analysis detected by a simple, graphical test

  1998cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• The well-built clinical question: a key to evidence-based decisions.

  1995cited by this paper
• American Association of Cardiovascular and Pulmonary Rehabilitation

  1985cited by this paper
• Aha Scientific Statement

  year unknowncited by this paper

• Depressive Symptoms, Functional Status, and Cardiovascular Parameters in Patients with Major Depressive Disorder Undergoing Cardiac Rehabilitation While Treated with Vortioxetine: A Prospective Observational Study.

  2026cites this paper
• 2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee.

  2025cites this paper
• Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases: An Umbrella Systematic Review and Meta-Analysis.

  2023cites this paper
• Islamic Spiritual Care, Depression, and Quality of Life Among Patients With Heart Disease: A Systematic Review

  2023cites this paper
• Feasibility of Integrating MEditatioN inTO heaRt Disease (the MENTOR Study)

  2023cites this paper
• Psychosocial management in cardiac rehabilitation: Current practices, recommendations, and opportunities.

  2022cites this paper
• Neuropsychiatric disorders in patients with heart failure: not to be ignored

  2022cites this paper